点 击 免 费 限 量 礼 盒 摘要 ： 近日，中国医学科学院发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理， 统计出19项仪器设备采购意向，预算总额达9825万元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 近日，中国医学科学院发布1 9项仪器设备采购意向，预算总额达9 8 2 5万元，涉及全自动化学发 光分析仪、全自动样本处理系统、三重四极杆液质联用仪、传统流式细胞分析仪、单细胞悬液 制备仪、低氧工作站、实时高通量光谱解析共均一化分析系统、表面等离子共振分子互作仪、 高速冷冻落地离心机等，预计采购时间为2 0 2 5年9~1 2月。 | | | | 12 | | --- | --- | --- | --- | | | | | 月 | | | | | 202 | | 皮肤病医院（中国医学科学院皮 | 因医院工作需要，拟购置多功能成像仪1 | | 5 | | 肤病研究所）多功能成像仪 | 台。具体内容详见后续招标公告。 | 50 | 年 | | | | | 12 | | | | | 月 | | | | | 202 | ...

Group 1 - The core project "Research on Lipoprotein Profile and New Intervention Targets Based on Large Natural Population Cohorts" has been officially approved, aiming to address residual risk in atherosclerotic cardiovascular diseases using VAP precision lipid testing technology [1] - VAP precision lipid testing technology utilizes vertical density gradient centrifugation to quantitatively measure major components and subcomponents of lipoproteins in human serum or plasma, providing significant value in risk prediction and individualized treatment for cardiovascular diseases [1] - The company has obtained Class II medical device registration for VAP-related reagents and instruments, and its testing methods have been included in national clinical guidelines, enhancing market recognition and clinical application of precision lipid products [1] Group 2 - The company has over 20 years of experience in the IVD industry, with a comprehensive product line covering various technology platforms, making it one of the most complete and diverse IVD manufacturers in China [2] - The strategic layout of the company focuses on the synergy of diagnostic instruments, core diagnostic products, and diagnostic services, supported by multiple R&D centers and collaborations with universities and research institutions [2] - As of the end of 2024, the company has obtained 49 diagnostic instrument registration certificates and 459 supporting reagent registration certificates, covering essential equipment for various diagnostic needs [2] Group 3 - The company is the first Chinese IVD manufacturer to join JCTLM, promoting standardization and global recognition of test results, and has participated in the development of over 30 international and national standard materials [3] - The collaboration with Peking University First Hospital on the national major science and technology project signifies a breakthrough in the integration of industry, academia, and research [3] - The company plans to increase R&D investment and deepen technological innovation, aiming to contribute to chronic disease management and prevention in alignment with the "Healthy China 2030" strategy [3]

Core Insights - The Yangtze River Delta (YRD) region's new energy vehicle (NEV) industry achieved significant production in Q1 2025, with over 840,000 vehicles produced, accounting for nearly 30% of the national total, continuing its status as a production hub [1] - The region is transitioning from the "first half of electrification" to the "second half of intelligence," driven by leading companies like CATL, NIO, and Tesla, but faces challenges such as overcapacity, declining penetration rates, and regional collaboration barriers [1][5] Industry Structure and Collaboration - The YRD NEV industry is moving from "local breakthroughs" to a "system layout," with clear functional positioning among Jiangsu, Shanghai, Zhejiang, and Anhui, forming a complete industrial chain from vehicles to batteries, chips, and components [2] - Shanghai is building a head ecosystem around vehicle manufacturing and intelligent driving, with Tesla's Shanghai Gigafactory expected to deliver 910,000 vehicles in 2024, representing nearly half of global capacity [2] - Jiangsu focuses on power batteries, housing over 190 key enterprises, including CATL and BYD, establishing a leading lithium battery production base [2] - Zhejiang's NEV industry cluster is projected to exceed 1 trillion yuan in revenue by 2024, growing by 19.5%, but faces challenges due to reliance on small private enterprises and limited financing [3] - Anhui's NEV production is expected to reach 1.684 million units in 2024, a 94.5% increase, with policies driving growth and establishing a "vehicle-software-testing" ecosystem [3] Challenges in Collaboration and Financial Support - The YRD NEV industry faces collaboration obstacles, including inconsistent data standards and unreasonable capital allocation, hindering cross-regional operations and testing [3][4] - Local industrial funds prioritize local projects, limiting support for cross-regional enterprises, exemplified by Hefei's targeted support for NIO, which has not significantly impacted other cities [4] Transition to Intelligent Systems - The global NEV market is experiencing a slowdown, with penetration rates dropping from 53.2% to 41.5% between September 2024 and January 2025, indicating a need for a shift from manufacturing to intelligent systems [5] - The YRD region has a solid foundation for intelligent transformation, with Shanghai leading in high-end electronic architecture and autonomous driving testing platforms [5][6] - However, the software ecosystem remains fragmented, with strong vehicle and chip companies but weak middleware, limiting the formation of a complete ecosystem [6][7] - To advance the NEV industry into the "second growth curve," the YRD must enhance software collaboration and public support capabilities [7]